laboratory biomarker analysis
Diagnostic TestResults of common laboratory tests obtained during routine care in the pre-procedural period (simple blood morphology, creatinine, GFR, NTproBNP). Inflammatory indices - NLR, MLR, PLR
NCT Number: NCT07258706
The aim of the project is to evaluate demographic, clinical, and laboratory variations in patients with aortic stenosis treated with TAVI in different countries. Moreover, the study will evaluate interpopulation differences in aortic root anatomy based on computed tomography analysis.
Interested in participating?
Request Info18 year and older
All sexes
Observational
San Bortolo's Hospital, Division of Cardiac Surgery and Division of Cardiology, Vicenza, Italy, Vicenza, Italy
Aortic stenosis represents the most common valvular heart disease in developed countries, with a significant epidemiologic increase related to the aging population. Currently, surgical and transcatheter interventions are the only therapeutic options, as pharmacotherapy is still insufficient in the disease management. Transcatheter aortic valve implantation is recommended in selected groups of patients and provides optimal short and long-term outcomes.
Racial and ethnic disparities in aortic stenosis prevalence, management, and outcomes of treatment have been postulated. Data on discrepancies in aortic stenosis characteristics in patients qualified for transcatheter aortic valve implantation across populations are lacking.
The current project will conduct the analysis in populations of patients with aortic stenosis qualified for transcatheter aortic valve implantation from different countries to reveal potential disparities in clinical characteristics and in requirements for variations in prostheses sizes.
This is a retrospective, multicentre, observational registry of patients with severe aortic stenosis qualified for transcatheter aortic valve implantation.
Inclusion criteria
- each site will include consecutive 100 patients who underwent transcatheter aortic valve implantation between January and June 2025.
Exclusion criteria
- active infection (chronic inflammatory disease or neoplasm is not an exclusion criterion, however, will be considered in the laboratory analysis)
Data concerning
Simple procedural results (inc. prosthesis type and size) and outcomes (survival, bleeding, vascular complications, and acute kidney injury) will be recorded.
Collected data will be compared between study populations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Results of common laboratory tests obtained during routine care in the pre-procedural period (simple blood morphology, creatinine, GFR, NTproBNP). Inflammatory indices - NLR, MLR, PLR
Results of CT analysis performed as a routine diagnostic examination in the pre-procedural period will be recorded.
Time frame: Baseline
Aortic annulus diameter in milimeters based on CT image
Time frame: Baseline
Aortic annulus area in squared milimeters based on CT image
Time frame: Baseline
Aortic annulus perimeter in milimeters based on CT image
Time frame: Baseline
Ilio-femoral artery diameter in milimeter based on CT image
Time frame: Baseline
This measurement is used to compute ratio of cell types using whole blood count
Time frame: Baseline
Number of monocytes identified in blood sample using automatic whole blood count. It is used to compute cell type ratio.
Time frame: Baseline
This measurement is used to compute ratio of cell types using whole blood count
Poznan University of Medical Sciences
Other
DIVER-TAVI Registry - Demographic and Interpopulation Variations in Evaluation and Results of TAVI
Acronym: DIVER-TAVI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05253794
Aortic Stenosis, Aortic Valve Disease
Ottawa, Ontario, Canada
View Trial DetailsNCT07201363
Aortic Stenosis, Aortic Valve Disease
Rijeka, Croatia
View Trial DetailsNCT02486367
Aortic Stenosis, Aortic Valve Disease
Cleveland, Ohio, United States
View Trial DetailsNCT07317804
Aortic Stenosis, Aortic Valve Disease
Beijing, Beijing Municipality, China
View Trial Details